Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for ZNF263
Z-value: 1.36
Motif logo
Transcription factors associated with ZNF263
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF263
|
ENSG00000006194.6 | zinc finger protein 263 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZNF263 | hg19_v2_chr16_+_3313791_3313834 | -0.16 | 1.8e-02 | Click! |
Activity profile of ZNF263 motif
Sorted Z-values of ZNF263 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr5_+_137801160 | 26.01 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
| chr12_+_53773944 | 25.60 |
ENST00000551969.1
ENST00000327443.4 |
SP1
|
Sp1 transcription factor |
| chr14_-_27066960 | 18.74 |
ENST00000539517.2
|
NOVA1
|
neuro-oncological ventral antigen 1 |
| chr13_-_88323218 | 18.06 |
ENST00000436290.2
ENST00000453832.2 ENST00000606590.1 |
MIR4500HG
|
MIR4500 host gene (non-protein coding) |
| chr1_+_6845384 | 17.23 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
| chr12_-_6798616 | 16.93 |
ENST00000355772.4
ENST00000417772.3 ENST00000396801.3 ENST00000396799.2 |
ZNF384
|
zinc finger protein 384 |
| chrX_+_24167828 | 15.14 |
ENST00000379188.3
ENST00000419690.1 ENST00000379177.1 ENST00000304543.5 |
ZFX
|
zinc finger protein, X-linked |
| chr14_-_27066636 | 14.41 |
ENST00000267422.7
ENST00000344429.5 ENST00000574031.1 ENST00000465357.2 ENST00000547619.1 |
NOVA1
|
neuro-oncological ventral antigen 1 |
| chr12_-_6798523 | 14.27 |
ENST00000319770.3
|
ZNF384
|
zinc finger protein 384 |
| chr12_-_91573132 | 14.23 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
| chr14_+_95078714 | 14.03 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
| chr12_-_6798410 | 13.98 |
ENST00000361959.3
ENST00000436774.2 ENST00000544482.1 |
ZNF384
|
zinc finger protein 384 |
| chr7_-_150038704 | 13.50 |
ENST00000466675.1
ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2 |
| chr19_+_55587266 | 13.25 |
ENST00000201647.6
ENST00000540810.1 |
EPS8L1
|
EPS8-like 1 |
| chr12_+_6930813 | 12.34 |
ENST00000428545.2
|
GPR162
|
G protein-coupled receptor 162 |
| chr8_+_26435359 | 12.21 |
ENST00000311151.5
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr14_-_81687197 | 12.02 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
| chr12_+_6930703 | 11.62 |
ENST00000311268.3
|
GPR162
|
G protein-coupled receptor 162 |
| chr3_-_127542051 | 11.22 |
ENST00000398104.1
|
MGLL
|
monoglyceride lipase |
| chr12_-_91573249 | 11.21 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
| chr22_+_29876197 | 10.85 |
ENST00000310624.6
|
NEFH
|
neurofilament, heavy polypeptide |
| chr12_+_6930964 | 10.28 |
ENST00000382315.3
|
GPR162
|
G protein-coupled receptor 162 |
| chr12_+_54332535 | 10.20 |
ENST00000243056.3
|
HOXC13
|
homeobox C13 |
| chr17_-_27278304 | 10.16 |
ENST00000577226.1
|
PHF12
|
PHD finger protein 12 |
| chr10_-_79397391 | 9.98 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr1_+_160085501 | 9.93 |
ENST00000361216.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chr3_-_133614597 | 9.74 |
ENST00000285208.4
ENST00000460865.3 |
RAB6B
|
RAB6B, member RAS oncogene family |
| chr17_+_77020224 | 9.56 |
ENST00000339142.2
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr5_-_149535421 | 9.44 |
ENST00000261799.4
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
| chr15_-_90358048 | 9.42 |
ENST00000300060.6
ENST00000560137.1 |
ANPEP
|
alanyl (membrane) aminopeptidase |
| chr14_-_60337684 | 9.37 |
ENST00000267484.5
|
RTN1
|
reticulon 1 |
| chr7_+_94023873 | 9.31 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
| chr18_-_51750948 | 9.29 |
ENST00000583046.1
ENST00000398398.2 |
MBD2
|
methyl-CpG binding domain protein 2 |
| chr10_-_79397316 | 9.22 |
ENST00000372421.5
ENST00000457953.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr12_-_91573316 | 9.11 |
ENST00000393155.1
|
DCN
|
decorin |
| chr3_-_133614421 | 9.10 |
ENST00000543906.1
|
RAB6B
|
RAB6B, member RAS oncogene family |
| chr20_+_19193269 | 9.05 |
ENST00000328041.6
|
SLC24A3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
| chr12_+_53443680 | 9.01 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
| chr17_+_77020325 | 9.00 |
ENST00000311661.4
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr10_-_79397202 | 8.93 |
ENST00000372437.1
ENST00000372408.2 ENST00000372403.4 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr1_+_209859510 | 8.83 |
ENST00000367028.2
ENST00000261465.1 |
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
| chr4_-_5891918 | 8.74 |
ENST00000512574.1
|
CRMP1
|
collapsin response mediator protein 1 |
| chr11_-_113746212 | 8.69 |
ENST00000537642.1
ENST00000537706.1 ENST00000544750.1 ENST00000260188.5 ENST00000540925.1 |
USP28
|
ubiquitin specific peptidase 28 |
| chr3_-_127542021 | 8.62 |
ENST00000434178.2
|
MGLL
|
monoglyceride lipase |
| chr15_-_63674034 | 8.55 |
ENST00000344366.3
ENST00000422263.2 |
CA12
|
carbonic anhydrase XII |
| chr11_-_66725837 | 8.46 |
ENST00000393958.2
ENST00000393960.1 ENST00000524491.1 ENST00000355677.3 |
PC
|
pyruvate carboxylase |
| chr15_-_71146480 | 8.41 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
| chr11_-_66336060 | 8.32 |
ENST00000310325.5
|
CTSF
|
cathepsin F |
| chr14_+_75746340 | 8.30 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr19_+_36359341 | 8.23 |
ENST00000221891.4
|
APLP1
|
amyloid beta (A4) precursor-like protein 1 |
| chr11_+_695380 | 8.16 |
ENST00000397510.3
|
TMEM80
|
transmembrane protein 80 |
| chr8_+_22462532 | 8.15 |
ENST00000389279.3
|
CCAR2
|
cell cycle and apoptosis regulator 2 |
| chr18_-_56940611 | 8.06 |
ENST00000256852.7
ENST00000334889.3 |
RAX
|
retina and anterior neural fold homeobox |
| chr3_-_120170052 | 8.03 |
ENST00000295633.3
|
FSTL1
|
follistatin-like 1 |
| chr2_+_74120094 | 7.94 |
ENST00000409731.3
ENST00000345517.3 ENST00000409918.1 ENST00000442912.1 ENST00000409624.1 |
ACTG2
|
actin, gamma 2, smooth muscle, enteric |
| chrX_+_153237740 | 7.82 |
ENST00000369982.4
|
TMEM187
|
transmembrane protein 187 |
| chr7_-_38670957 | 7.78 |
ENST00000325590.5
ENST00000428293.2 |
AMPH
|
amphiphysin |
| chr14_-_23834411 | 7.78 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
| chr11_-_71639670 | 7.74 |
ENST00000533047.1
ENST00000529844.1 |
RP11-849H4.2
|
Putative short transient receptor potential channel 2-like protein |
| chr11_-_113746277 | 7.73 |
ENST00000003302.4
ENST00000545540.1 |
USP28
|
ubiquitin specific peptidase 28 |
| chr6_+_31949801 | 7.66 |
ENST00000428956.2
ENST00000498271.1 |
C4A
|
complement component 4A (Rodgers blood group) |
| chr2_-_216300784 | 7.63 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chrX_+_103031421 | 7.62 |
ENST00000433491.1
ENST00000418604.1 ENST00000443502.1 |
PLP1
|
proteolipid protein 1 |
| chrX_-_110039286 | 7.58 |
ENST00000434224.1
|
CHRDL1
|
chordin-like 1 |
| chrY_+_2803322 | 7.55 |
ENST00000383052.1
ENST00000155093.3 ENST00000449237.1 ENST00000443793.1 |
ZFY
|
zinc finger protein, Y-linked |
| chr12_+_53443963 | 7.52 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
| chr6_+_31982539 | 7.50 |
ENST00000435363.2
ENST00000425700.2 |
C4B
|
complement component 4B (Chido blood group) |
| chrX_+_103031758 | 7.44 |
ENST00000303958.2
ENST00000361621.2 |
PLP1
|
proteolipid protein 1 |
| chr14_+_57857262 | 7.41 |
ENST00000555166.1
ENST00000556492.1 ENST00000554703.1 |
NAA30
|
N(alpha)-acetyltransferase 30, NatC catalytic subunit |
| chr6_-_31514333 | 7.36 |
ENST00000376151.4
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
| chr10_-_118502070 | 7.34 |
ENST00000369209.3
|
HSPA12A
|
heat shock 70kDa protein 12A |
| chr10_+_76586348 | 7.34 |
ENST00000372724.1
ENST00000287239.4 ENST00000372714.1 |
KAT6B
|
K(lysine) acetyltransferase 6B |
| chrX_-_110039038 | 7.33 |
ENST00000372042.1
ENST00000482160.1 ENST00000444321.2 ENST00000218054.4 |
CHRDL1
|
chordin-like 1 |
| chr4_-_153457197 | 7.31 |
ENST00000281708.4
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
| chrX_+_23352133 | 7.29 |
ENST00000379361.4
|
PTCHD1
|
patched domain containing 1 |
| chr6_-_31514516 | 7.22 |
ENST00000303892.5
ENST00000483251.1 |
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
| chr9_+_126773880 | 7.17 |
ENST00000373615.4
|
LHX2
|
LIM homeobox 2 |
| chr11_-_6341844 | 7.17 |
ENST00000303927.3
|
PRKCDBP
|
protein kinase C, delta binding protein |
| chr17_-_2206801 | 7.15 |
ENST00000544865.1
|
SMG6
|
SMG6 nonsense mediated mRNA decay factor |
| chr10_+_123872483 | 7.14 |
ENST00000369001.1
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr6_-_169654139 | 7.09 |
ENST00000366787.3
|
THBS2
|
thrombospondin 2 |
| chr3_+_35681081 | 7.07 |
ENST00000428373.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr1_+_36023035 | 7.06 |
ENST00000373253.3
|
NCDN
|
neurochondrin |
| chr3_-_127541679 | 7.05 |
ENST00000265052.5
|
MGLL
|
monoglyceride lipase |
| chr5_-_146833485 | 6.98 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chr19_-_38714847 | 6.93 |
ENST00000420980.2
ENST00000355526.4 |
DPF1
|
D4, zinc and double PHD fingers family 1 |
| chr22_+_17082732 | 6.92 |
ENST00000558085.2
ENST00000592918.1 ENST00000400593.2 ENST00000592107.1 ENST00000426585.1 ENST00000591299.1 |
TPTEP1
|
transmembrane phosphatase with tensin homology pseudogene 1 |
| chr19_-_7968427 | 6.89 |
ENST00000539278.1
|
AC010336.1
|
Uncharacterized protein |
| chr11_-_73309228 | 6.86 |
ENST00000356467.4
ENST00000064778.4 |
FAM168A
|
family with sequence similarity 168, member A |
| chr8_+_26371763 | 6.86 |
ENST00000521913.1
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr2_-_50574856 | 6.85 |
ENST00000342183.5
|
NRXN1
|
neurexin 1 |
| chr19_-_47975417 | 6.80 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr1_+_25944341 | 6.79 |
ENST00000263979.3
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
| chr20_+_54933971 | 6.75 |
ENST00000371384.3
ENST00000437418.1 |
FAM210B
|
family with sequence similarity 210, member B |
| chrX_+_24167746 | 6.65 |
ENST00000428571.1
ENST00000539115.1 |
ZFX
|
zinc finger protein, X-linked |
| chr7_+_26438187 | 6.63 |
ENST00000439120.1
ENST00000430548.1 ENST00000421862.1 ENST00000449537.1 ENST00000420774.1 ENST00000418758.2 |
AC004540.5
|
AC004540.5 |
| chr19_+_58790314 | 6.63 |
ENST00000196548.5
ENST00000608843.1 |
ZNF8
ZNF8
|
Zinc finger protein 8 zinc finger protein 8 |
| chrX_-_47479246 | 6.61 |
ENST00000295987.7
ENST00000340666.4 |
SYN1
|
synapsin I |
| chr11_-_6341724 | 6.60 |
ENST00000530979.1
|
PRKCDBP
|
protein kinase C, delta binding protein |
| chr13_-_46626847 | 6.60 |
ENST00000242848.4
ENST00000282007.3 |
ZC3H13
|
zinc finger CCCH-type containing 13 |
| chr11_-_64490634 | 6.53 |
ENST00000377559.3
ENST00000265459.6 |
NRXN2
|
neurexin 2 |
| chr4_+_55524085 | 6.52 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
| chr5_+_74807886 | 6.52 |
ENST00000514296.1
|
POLK
|
polymerase (DNA directed) kappa |
| chr3_+_189507460 | 6.51 |
ENST00000434928.1
|
TP63
|
tumor protein p63 |
| chr17_-_34890759 | 6.51 |
ENST00000431794.3
|
MYO19
|
myosin XIX |
| chr10_+_38299546 | 6.43 |
ENST00000374618.3
ENST00000432900.2 ENST00000458705.2 ENST00000469037.2 |
ZNF33A
|
zinc finger protein 33A |
| chr5_-_11904100 | 6.40 |
ENST00000359640.2
|
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr2_-_152955213 | 6.39 |
ENST00000427385.1
|
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit |
| chr2_-_26205340 | 6.39 |
ENST00000264712.3
|
KIF3C
|
kinesin family member 3C |
| chr8_+_22462145 | 6.38 |
ENST00000308511.4
ENST00000523801.1 ENST00000521301.1 |
CCAR2
|
cell cycle and apoptosis regulator 2 |
| chr7_-_143059780 | 6.35 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
| chr5_-_11904152 | 6.33 |
ENST00000304623.8
ENST00000458100.2 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr1_+_202317815 | 6.26 |
ENST00000608999.1
ENST00000336894.4 ENST00000480184.1 |
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
| chr8_+_22022653 | 6.23 |
ENST00000354870.5
ENST00000397816.3 ENST00000306349.8 |
BMP1
|
bone morphogenetic protein 1 |
| chr12_-_106641728 | 6.22 |
ENST00000378026.4
|
CKAP4
|
cytoskeleton-associated protein 4 |
| chr1_-_57889687 | 6.22 |
ENST00000371236.2
ENST00000371230.1 |
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila) |
| chr13_-_110959478 | 6.21 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
| chr5_-_134914673 | 6.13 |
ENST00000512158.1
|
CXCL14
|
chemokine (C-X-C motif) ligand 14 |
| chr11_-_62494821 | 6.06 |
ENST00000301785.5
|
HNRNPUL2
|
heterogeneous nuclear ribonucleoprotein U-like 2 |
| chr2_-_152955537 | 6.06 |
ENST00000201943.5
ENST00000539935.1 |
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit |
| chr14_-_93799360 | 6.06 |
ENST00000334746.5
ENST00000554565.1 ENST00000298896.3 |
BTBD7
|
BTB (POZ) domain containing 7 |
| chr15_-_57025759 | 6.00 |
ENST00000267807.7
|
ZNF280D
|
zinc finger protein 280D |
| chr11_-_7041466 | 6.00 |
ENST00000536068.1
ENST00000278314.4 |
ZNF214
|
zinc finger protein 214 |
| chr1_+_36023370 | 5.97 |
ENST00000356090.4
ENST00000373243.2 |
NCDN
|
neurochondrin |
| chr5_+_173472607 | 5.97 |
ENST00000303177.3
ENST00000519867.1 |
NSG2
|
Neuron-specific protein family member 2 |
| chr1_-_241520525 | 5.94 |
ENST00000366565.1
|
RGS7
|
regulator of G-protein signaling 7 |
| chr6_-_32077100 | 5.93 |
ENST00000375244.3
ENST00000375247.2 |
TNXB
|
tenascin XB |
| chr19_-_51504852 | 5.92 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr1_+_162039558 | 5.89 |
ENST00000530878.1
ENST00000361897.5 |
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein |
| chr18_+_46065483 | 5.89 |
ENST00000382998.4
|
CTIF
|
CBP80/20-dependent translation initiation factor |
| chr9_+_130911770 | 5.82 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
| chr7_-_19157248 | 5.79 |
ENST00000242261.5
|
TWIST1
|
twist family bHLH transcription factor 1 |
| chr15_-_83378638 | 5.78 |
ENST00000261722.3
|
AP3B2
|
adaptor-related protein complex 3, beta 2 subunit |
| chr15_-_83378611 | 5.76 |
ENST00000542200.1
|
AP3B2
|
adaptor-related protein complex 3, beta 2 subunit |
| chr9_-_122131696 | 5.74 |
ENST00000373964.2
ENST00000265922.3 |
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1 |
| chr4_+_3768075 | 5.74 |
ENST00000509482.1
ENST00000330055.5 |
ADRA2C
|
adrenoceptor alpha 2C |
| chr16_-_31085514 | 5.73 |
ENST00000300849.4
|
ZNF668
|
zinc finger protein 668 |
| chr17_-_34890709 | 5.71 |
ENST00000544606.1
|
MYO19
|
myosin XIX |
| chr19_+_50016411 | 5.67 |
ENST00000426395.3
ENST00000600273.1 ENST00000599988.1 |
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
| chrX_-_17879356 | 5.67 |
ENST00000331511.1
ENST00000415486.3 ENST00000545871.1 ENST00000451717.1 |
RAI2
|
retinoic acid induced 2 |
| chr2_-_51259292 | 5.66 |
ENST00000401669.2
|
NRXN1
|
neurexin 1 |
| chr13_+_110959598 | 5.63 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
| chr10_+_18429606 | 5.59 |
ENST00000324631.7
ENST00000352115.6 ENST00000377328.1 |
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
| chr15_-_77712477 | 5.58 |
ENST00000560626.2
|
PEAK1
|
pseudopodium-enriched atypical kinase 1 |
| chr2_+_203776937 | 5.58 |
ENST00000402905.3
ENST00000414490.1 ENST00000431787.1 ENST00000444724.1 ENST00000414857.1 ENST00000430899.1 ENST00000445120.1 ENST00000441569.1 ENST00000432024.1 ENST00000443740.1 ENST00000414439.1 ENST00000428585.1 ENST00000545253.1 ENST00000545262.1 ENST00000447539.1 ENST00000456821.2 ENST00000434998.1 ENST00000320443.8 |
CARF
|
calcium responsive transcription factor |
| chr10_+_18429671 | 5.53 |
ENST00000282343.8
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
| chr16_-_75590114 | 5.47 |
ENST00000568377.1
ENST00000565067.1 ENST00000258173.6 |
TMEM231
|
transmembrane protein 231 |
| chr3_-_149688655 | 5.45 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
| chr17_+_60704762 | 5.45 |
ENST00000303375.5
|
MRC2
|
mannose receptor, C type 2 |
| chr3_-_149688896 | 5.42 |
ENST00000239940.7
|
PFN2
|
profilin 2 |
| chr19_+_7968728 | 5.40 |
ENST00000397981.3
ENST00000545011.1 ENST00000397983.3 ENST00000397979.3 |
MAP2K7
|
mitogen-activated protein kinase kinase 7 |
| chr11_-_17565854 | 5.37 |
ENST00000005226.7
|
USH1C
|
Usher syndrome 1C (autosomal recessive, severe) |
| chr12_+_119616447 | 5.36 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
| chr5_-_95297534 | 5.36 |
ENST00000513343.1
ENST00000431061.2 |
ELL2
|
elongation factor, RNA polymerase II, 2 |
| chr17_-_40333150 | 5.32 |
ENST00000264661.3
|
KCNH4
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
| chr15_+_91427691 | 5.30 |
ENST00000559355.1
ENST00000394302.1 |
FES
|
feline sarcoma oncogene |
| chr17_+_73750699 | 5.27 |
ENST00000584939.1
|
ITGB4
|
integrin, beta 4 |
| chr2_+_111490161 | 5.26 |
ENST00000340561.4
|
ACOXL
|
acyl-CoA oxidase-like |
| chr9_-_113341985 | 5.24 |
ENST00000374469.1
|
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
| chr11_-_46722117 | 5.23 |
ENST00000311956.4
|
ARHGAP1
|
Rho GTPase activating protein 1 |
| chr10_-_53459319 | 5.23 |
ENST00000331173.4
|
CSTF2T
|
cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant |
| chrX_+_110187513 | 5.20 |
ENST00000446737.1
ENST00000425146.1 |
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3 |
| chr17_-_40333099 | 5.20 |
ENST00000607371.1
|
KCNH4
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
| chr1_+_150480576 | 5.20 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
| chr19_-_13617037 | 5.20 |
ENST00000360228.5
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
| chr12_+_57984965 | 5.20 |
ENST00000540759.2
ENST00000551772.1 ENST00000550465.1 ENST00000354947.5 |
PIP4K2C
|
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma |
| chr13_-_44361025 | 5.19 |
ENST00000261488.6
|
ENOX1
|
ecto-NOX disulfide-thiol exchanger 1 |
| chr3_-_50605150 | 5.16 |
ENST00000357203.3
|
C3orf18
|
chromosome 3 open reading frame 18 |
| chr15_-_64338521 | 5.15 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
| chr3_-_50605077 | 5.14 |
ENST00000426034.1
ENST00000441239.1 |
C3orf18
|
chromosome 3 open reading frame 18 |
| chr1_-_157108266 | 5.13 |
ENST00000326786.4
|
ETV3
|
ets variant 3 |
| chr19_+_36249057 | 5.08 |
ENST00000301165.5
ENST00000536950.1 ENST00000537459.1 ENST00000421853.2 |
C19orf55
|
chromosome 19 open reading frame 55 |
| chr1_-_144932316 | 5.07 |
ENST00000313431.9
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr2_-_51259641 | 5.04 |
ENST00000406316.2
ENST00000405581.1 |
NRXN1
|
neurexin 1 |
| chr3_+_184053703 | 5.03 |
ENST00000450976.1
ENST00000418281.1 ENST00000340957.5 ENST00000433578.1 |
FAM131A
|
family with sequence similarity 131, member A |
| chr2_-_51259528 | 5.02 |
ENST00000404971.1
|
NRXN1
|
neurexin 1 |
| chr13_+_31191920 | 5.00 |
ENST00000255304.4
|
USPL1
|
ubiquitin specific peptidase like 1 |
| chr17_+_34958001 | 5.00 |
ENST00000250156.7
|
MRM1
|
mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) |
| chr16_-_68482440 | 4.99 |
ENST00000219334.5
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
| chr2_-_51259229 | 4.98 |
ENST00000405472.3
|
NRXN1
|
neurexin 1 |
| chr1_+_25943959 | 4.93 |
ENST00000374332.4
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
| chr13_-_33002151 | 4.92 |
ENST00000495479.1
ENST00000343281.4 ENST00000464470.1 ENST00000380139.4 ENST00000380133.2 |
N4BP2L1
|
NEDD4 binding protein 2-like 1 |
| chr4_+_157997273 | 4.91 |
ENST00000541722.1
ENST00000512619.1 |
GLRB
|
glycine receptor, beta |
| chrX_-_47509887 | 4.89 |
ENST00000247161.3
ENST00000592066.1 ENST00000376983.3 |
ELK1
|
ELK1, member of ETS oncogene family |
| chrX_+_16804544 | 4.85 |
ENST00000380122.5
ENST00000398155.4 |
TXLNG
|
taxilin gamma |
| chr16_-_88923285 | 4.83 |
ENST00000542788.1
ENST00000569433.1 ENST00000268695.5 ENST00000568311.1 |
GALNS
|
galactosamine (N-acetyl)-6-sulfate sulfatase |
| chr16_-_28550320 | 4.82 |
ENST00000395641.2
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
| chr3_-_178789993 | 4.81 |
ENST00000432729.1
|
ZMAT3
|
zinc finger, matrin-type 3 |
| chr19_+_48216600 | 4.80 |
ENST00000263277.3
ENST00000538399.1 |
EHD2
|
EH-domain containing 2 |
| chr11_+_46316677 | 4.78 |
ENST00000534787.1
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1 |
| chr2_-_89157161 | 4.78 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
| chr4_-_7941596 | 4.77 |
ENST00000420658.1
ENST00000358461.2 |
AFAP1
|
actin filament associated protein 1 |
| chr7_+_150498610 | 4.77 |
ENST00000461345.1
|
TMEM176A
|
transmembrane protein 176A |
| chr7_+_55086703 | 4.76 |
ENST00000455089.1
ENST00000342916.3 ENST00000344576.2 ENST00000420316.2 |
EGFR
|
epidermal growth factor receptor |
| chr3_+_38323785 | 4.75 |
ENST00000466887.1
ENST00000448498.1 |
SLC22A14
|
solute carrier family 22, member 14 |
| chr3_+_167453493 | 4.73 |
ENST00000295777.5
ENST00000472747.2 |
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
| chr1_-_6321035 | 4.73 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr19_+_45349432 | 4.73 |
ENST00000252485.4
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
| chr1_+_224803995 | 4.71 |
ENST00000272133.3
|
CNIH3
|
cornichon family AMPA receptor auxiliary protein 3 |
| chr1_+_36690011 | 4.71 |
ENST00000354618.5
ENST00000469141.2 ENST00000478853.1 |
THRAP3
|
thyroid hormone receptor associated protein 3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF263
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.7 | 26.0 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) regulation of progesterone biosynthetic process(GO:2000182) |
| 4.7 | 9.4 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 4.6 | 18.6 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 4.5 | 27.2 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 4.5 | 13.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 4.3 | 34.1 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 3.8 | 26.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 3.7 | 14.9 | GO:0048749 | compound eye development(GO:0048749) |
| 3.6 | 39.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 3.6 | 10.9 | GO:0048936 | neurofilament bundle assembly(GO:0033693) peripheral nervous system neuron axonogenesis(GO:0048936) |
| 3.3 | 3.3 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 2.9 | 8.7 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 2.9 | 34.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 2.9 | 8.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 2.8 | 8.5 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.6 | 7.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 2.5 | 7.6 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 2.5 | 12.7 | GO:0070384 | Harderian gland development(GO:0070384) |
| 2.4 | 9.7 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 2.4 | 9.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 2.3 | 4.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 2.2 | 6.5 | GO:0048170 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 2.1 | 6.2 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 2.1 | 6.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 2.1 | 12.4 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 2.0 | 6.1 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 2.0 | 9.9 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 2.0 | 11.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 2.0 | 9.9 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 2.0 | 11.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 1.9 | 5.8 | GO:2000276 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.9 | 17.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 1.8 | 5.5 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.8 | 5.4 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 1.7 | 5.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 1.6 | 8.2 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 1.6 | 4.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 1.6 | 6.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 1.6 | 3.2 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
| 1.6 | 6.4 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 1.6 | 12.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 1.6 | 4.8 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 1.5 | 4.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.5 | 4.5 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 1.5 | 4.5 | GO:0007538 | primary sex determination(GO:0007538) |
| 1.5 | 10.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 1.5 | 11.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.5 | 7.3 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 1.5 | 18.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.4 | 5.7 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 1.4 | 14.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 1.3 | 10.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 1.3 | 4.0 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 1.3 | 9.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.3 | 3.9 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 1.3 | 15.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 1.3 | 1.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 1.3 | 5.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 1.2 | 11.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 1.2 | 3.7 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 1.2 | 2.4 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 1.1 | 4.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 1.1 | 14.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 1.1 | 4.4 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 1.1 | 15.5 | GO:0035878 | nail development(GO:0035878) |
| 1.1 | 3.3 | GO:0021586 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 1.1 | 4.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 1.1 | 8.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 1.0 | 2.1 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 1.0 | 6.3 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.0 | 7.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 1.0 | 3.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 1.0 | 2.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 1.0 | 11.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 1.0 | 3.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 1.0 | 3.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 1.0 | 11.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 1.0 | 18.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 1.0 | 2.0 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 1.0 | 6.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 1.0 | 3.9 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.9 | 4.7 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.9 | 2.8 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.9 | 5.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.9 | 7.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.9 | 2.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.9 | 10.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.9 | 3.5 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
| 0.9 | 6.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.9 | 1.8 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.9 | 2.6 | GO:0045925 | female courtship behavior(GO:0008050) positive regulation of female receptivity(GO:0045925) |
| 0.9 | 3.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.9 | 2.6 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.9 | 5.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.8 | 3.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.8 | 5.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.8 | 2.5 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 0.8 | 4.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.8 | 19.3 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.8 | 15.0 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.8 | 9.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.8 | 11.2 | GO:0021794 | thalamus development(GO:0021794) |
| 0.8 | 2.4 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.8 | 0.8 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.8 | 11.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.8 | 1.6 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
| 0.8 | 4.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.8 | 3.1 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.8 | 3.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.8 | 2.3 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.8 | 7.6 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.7 | 2.2 | GO:0048378 | vacuolar phosphate transport(GO:0007037) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.7 | 3.0 | GO:1900166 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.7 | 3.0 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.7 | 2.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.7 | 2.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.7 | 11.5 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.7 | 4.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.7 | 0.7 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
| 0.7 | 2.1 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.7 | 5.6 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.7 | 2.8 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) |
| 0.7 | 2.0 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.7 | 12.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.7 | 2.0 | GO:1990029 | pulmonary valve formation(GO:0003193) atrial ventricular junction remodeling(GO:0003294) foramen ovale closure(GO:0035922) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.7 | 2.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.7 | 3.3 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 0.7 | 3.3 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.7 | 3.3 | GO:1903285 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 0.7 | 2.0 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.6 | 1.9 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
| 0.6 | 7.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.6 | 1.3 | GO:0061074 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
| 0.6 | 12.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.6 | 1.9 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.6 | 1.9 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.6 | 4.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.6 | 2.4 | GO:0045715 | transforming growth factor-beta secretion(GO:0038044) negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.6 | 8.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.6 | 14.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.6 | 6.0 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.6 | 4.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.6 | 1.8 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.6 | 10.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.6 | 3.5 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.6 | 8.8 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.6 | 4.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.6 | 3.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.6 | 5.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.6 | 1.7 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.6 | 1.7 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.6 | 3.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.6 | 1.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.6 | 6.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.6 | 4.5 | GO:0070779 | sulfur amino acid transport(GO:0000101) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.5 | 2.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.5 | 3.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.5 | 2.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.5 | 1.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.5 | 7.3 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.5 | 2.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.5 | 3.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 3.1 | GO:0009624 | response to nematode(GO:0009624) |
| 0.5 | 3.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.5 | 1.5 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.5 | 11.2 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.5 | 3.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.5 | 2.5 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.5 | 5.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.5 | 9.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.5 | 3.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.5 | 4.9 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.5 | 2.9 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.5 | 3.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.5 | 5.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.5 | 1.4 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.5 | 1.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.5 | 1.4 | GO:0007500 | mesodermal cell fate determination(GO:0007500) negative regulation of muscle hyperplasia(GO:0014740) cellular response to cycloheximide(GO:0071409) |
| 0.5 | 2.7 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.5 | 1.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.4 | 2.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.4 | 6.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.4 | 1.3 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.4 | 2.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.4 | 2.6 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.4 | 3.9 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.4 | 8.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.4 | 14.6 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.4 | 2.1 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.4 | 1.3 | GO:0032900 | regulation of neurotrophin production(GO:0032899) negative regulation of neurotrophin production(GO:0032900) |
| 0.4 | 2.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.4 | 6.4 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.4 | 2.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.4 | 4.1 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.4 | 3.7 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.4 | 4.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.4 | 4.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.4 | 1.6 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.4 | 1.6 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.4 | 2.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.4 | 2.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.4 | 5.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.4 | 1.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.4 | 1.5 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.4 | 1.5 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.4 | 2.7 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.4 | 2.7 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.4 | 3.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.4 | 2.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.4 | 1.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.4 | 7.8 | GO:0033622 | integrin activation(GO:0033622) |
| 0.4 | 1.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 | 1.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.3 | 5.6 | GO:0030509 | BMP signaling pathway(GO:0030509) |
| 0.3 | 2.4 | GO:0090382 | phagosome maturation(GO:0090382) |
| 0.3 | 3.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.3 | 3.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.3 | 4.8 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.3 | 1.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.3 | 2.1 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 5.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 | 4.0 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.3 | 1.7 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.3 | 7.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.3 | 1.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.3 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.3 | 3.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.3 | 2.0 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.3 | 1.0 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.3 | 6.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 | 6.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.3 | 13.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.3 | 1.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 | 12.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.3 | 1.6 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.3 | 4.4 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
| 0.3 | 6.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.3 | 1.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.3 | 2.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.3 | 7.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.3 | 1.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.3 | 3.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.3 | 0.8 | GO:0072007 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.3 | 2.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.3 | 2.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
| 0.3 | 2.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.3 | 1.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.3 | 4.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.3 | 3.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.3 | 4.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.3 | 1.9 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.3 | 3.5 | GO:0006273 | lagging strand elongation(GO:0006273) |
| 0.3 | 0.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.3 | 2.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.3 | 0.8 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.3 | 4.2 | GO:0060044 | positive regulation of oligodendrocyte differentiation(GO:0048714) negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.3 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.3 | 3.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.3 | 1.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.3 | 1.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.3 | 2.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.3 | 3.1 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.3 | 9.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.3 | 2.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.3 | 0.8 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.3 | 1.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.3 | 1.8 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.2 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
| 0.2 | 1.2 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.2 | 19.7 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.2 | 11.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.2 | 3.6 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 | 7.9 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
| 0.2 | 6.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 22.2 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.2 | 1.2 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.2 | 1.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 | 3.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.2 | 4.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.2 | 1.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.2 | 2.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 | 12.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 1.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.2 | 0.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 | 2.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.2 | 0.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.2 | 1.1 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.2 | 2.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.2 | 6.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.2 | 2.2 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.2 | 0.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.2 | 6.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 | 3.7 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.2 | 0.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.2 | 1.0 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.2 | 7.6 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.2 | 3.5 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
| 0.2 | 2.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.2 | 1.7 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.2 | 2.6 | GO:0006024 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.2 | 1.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.2 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.2 | 3.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.2 | 3.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.2 | 0.5 | GO:2001038 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) regulation of cellular response to drug(GO:2001038) |
| 0.2 | 2.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.2 | 2.2 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.2 | 2.4 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 2.2 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.2 | 0.5 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.2 | 1.7 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.2 | 0.7 | GO:0051918 | negative regulation of plasminogen activation(GO:0010757) negative regulation of fibrinolysis(GO:0051918) |
| 0.2 | 3.6 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.2 | 2.8 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.2 | 0.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.2 | 4.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.2 | 4.4 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.2 | 3.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 | 4.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.2 | 3.7 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.2 | 2.3 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.2 | 0.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 1.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.2 | 1.5 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 20.2 | GO:0007626 | locomotory behavior(GO:0007626) |
| 0.2 | 5.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.2 | 1.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 1.3 | GO:1903792 | negative regulation of anion transport(GO:1903792) |
| 0.1 | 5.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 | 2.5 | GO:0021549 | cerebellum development(GO:0021549) |
| 0.1 | 2.7 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
| 0.1 | 1.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 | 3.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 1.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.1 | 2.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.1 | 1.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 2.8 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.1 | 0.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 | 3.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 2.0 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.1 | 1.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 1.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 1.8 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 0.1 | 4.3 | GO:0010962 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
| 0.1 | 0.8 | GO:0045837 | negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
| 0.1 | 3.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 1.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 2.7 | GO:0003279 | cardiac septum development(GO:0003279) |
| 0.1 | 2.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.1 | 6.3 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.1 | 0.6 | GO:0048641 | regulation of skeletal muscle tissue development(GO:0048641) negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 3.0 | GO:0008542 | visual learning(GO:0008542) |
| 0.1 | 0.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.1 | 1.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
| 0.1 | 3.1 | GO:0042339 | keratan sulfate biosynthetic process(GO:0018146) keratan sulfate metabolic process(GO:0042339) |
| 0.1 | 14.5 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.1 | 0.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 | 0.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 | 2.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 0.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 0.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 1.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.1 | 2.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.1 | 2.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 0.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 | 1.1 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.1 | 4.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 | 1.1 | GO:0042476 | odontogenesis(GO:0042476) |
| 0.1 | 2.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 3.8 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
| 0.1 | 1.4 | GO:0007622 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.1 | 2.4 | GO:0001947 | heart looping(GO:0001947) |
| 0.1 | 1.6 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 | 1.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 | 0.7 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.1 | 0.6 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 | 4.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 2.0 | GO:0007416 | synapse assembly(GO:0007416) |
| 0.1 | 10.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.9 | GO:0048754 | branching morphogenesis of an epithelial tube(GO:0048754) |
| 0.1 | 3.0 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 3.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.1 | 1.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 4.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 | 1.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 0.7 | GO:0048477 | oogenesis(GO:0048477) |
| 0.1 | 1.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 4.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 1.1 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
| 0.1 | 1.7 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 6.9 | GO:0042594 | response to starvation(GO:0042594) |
| 0.1 | 6.7 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.1 | 0.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 2.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 | 0.7 | GO:0072678 | T cell migration(GO:0072678) |
| 0.1 | 1.8 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 | 2.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 1.2 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 3.0 | GO:0007422 | peripheral nervous system development(GO:0007422) |
| 0.1 | 7.1 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
| 0.1 | 2.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.1 | 0.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.1 | 2.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 0.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 0.8 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 1.7 | GO:0061053 | somite development(GO:0061053) |
| 0.1 | 1.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.0 | 2.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 4.1 | GO:0046718 | viral entry into host cell(GO:0046718) |
| 0.0 | 0.4 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.0 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.9 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.0 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 | 2.1 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.0 | 0.2 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 | 0.7 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
| 0.0 | 1.0 | GO:0035904 | aorta development(GO:0035904) |
| 0.0 | 1.1 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 | 1.0 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 | 1.6 | GO:0050808 | synapse organization(GO:0050808) |
| 0.0 | 1.6 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
| 0.0 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 | 0.7 | GO:0021761 | limbic system development(GO:0021761) |
| 0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 2.5 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
| 0.0 | 3.8 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.0 | 0.4 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
| 0.0 | 0.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 0.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 1.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 1.5 | GO:0042107 | cytokine metabolic process(GO:0042107) |
| 0.0 | 1.1 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 | 0.9 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
| 0.0 | 0.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.8 | GO:0061337 | cardiac conduction(GO:0061337) |
| 0.0 | 1.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
| 0.0 | 0.5 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 0.0 | 0.3 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.0 | 0.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.0 | 0.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.8 | 14.5 | GO:0044609 | DBIRD complex(GO:0044609) |
| 2.8 | 11.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 2.7 | 8.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 2.5 | 34.6 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 1.9 | 7.4 | GO:0031417 | NatC complex(GO:0031417) |
| 1.8 | 7.3 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 1.7 | 14.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 1.6 | 4.9 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 1.6 | 4.8 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 1.4 | 4.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 1.4 | 17.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 1.4 | 8.5 | GO:0097443 | sorting endosome(GO:0097443) |
| 1.4 | 4.2 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 1.3 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 1.3 | 17.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 1.3 | 10.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 1.2 | 4.6 | GO:0031673 | H zone(GO:0031673) |
| 1.1 | 4.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.1 | 20.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 1.1 | 11.0 | GO:0097427 | microtubule bundle(GO:0097427) |
| 1.1 | 8.6 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.0 | 11.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 1.0 | 2.0 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 1.0 | 6.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.9 | 6.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.9 | 5.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.9 | 12.8 | GO:0005883 | neurofilament(GO:0005883) |
| 0.8 | 16.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.8 | 3.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.8 | 2.4 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) integrin alphav-beta8 complex(GO:0034686) |
| 0.8 | 8.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.7 | 5.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.7 | 4.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.7 | 9.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.6 | 8.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.6 | 2.5 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.6 | 3.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 0.6 | 3.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.6 | 7.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.6 | 14.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.6 | 2.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.6 | 25.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.6 | 2.2 | GO:1990075 | kinesin II complex(GO:0016939) periciliary membrane compartment(GO:1990075) |
| 0.5 | 2.2 | GO:0035838 | growing cell tip(GO:0035838) |
| 0.5 | 2.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.5 | 3.7 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.5 | 3.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.5 | 4.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.5 | 2.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.5 | 2.4 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.5 | 5.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.5 | 46.4 | GO:0005901 | caveola(GO:0005901) |
| 0.5 | 6.9 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.5 | 1.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.5 | 2.7 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.4 | 6.2 | GO:0042599 | lamellar body(GO:0042599) |
| 0.4 | 2.2 | GO:0071546 | pi-body(GO:0071546) |
| 0.4 | 4.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.4 | 1.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.4 | 3.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.4 | 38.0 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.4 | 2.0 | GO:0033647 | host cell cytoplasm(GO:0030430) host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) host cell cytoplasm part(GO:0033655) tubulin complex(GO:0045298) |
| 0.4 | 20.7 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.4 | 6.5 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 1.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.4 | 2.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.3 | 5.5 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 3.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 6.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.3 | 2.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.3 | 6.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.3 | 1.6 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.3 | 9.1 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 1.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.3 | 1.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.3 | 10.6 | GO:0043679 | axon terminus(GO:0043679) |
| 0.3 | 0.3 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.3 | 4.5 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.3 | 8.6 | GO:0032420 | stereocilium(GO:0032420) |
| 0.3 | 9.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.3 | 24.9 | GO:0016459 | myosin complex(GO:0016459) |
| 0.3 | 6.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.3 | 2.4 | GO:0034464 | BBSome(GO:0034464) |
| 0.3 | 34.9 | GO:0043204 | perikaryon(GO:0043204) |
| 0.3 | 22.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.3 | 1.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.2 | 1.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.2 | 1.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.2 | 3.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.2 | 3.3 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 8.4 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 3.0 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 8.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 1.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.2 | 17.9 | GO:0005604 | basement membrane(GO:0005604) |
| 0.2 | 6.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.2 | 11.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.2 | 4.9 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.2 | 4.3 | GO:0042627 | chylomicron(GO:0042627) |
| 0.2 | 4.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.2 | 1.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.2 | 10.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.2 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 2.5 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.2 | 1.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.2 | 7.2 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.2 | 10.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.2 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 20.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 1.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 10.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.1 | 3.0 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 36.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 3.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 9.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 11.7 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 7.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 6.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 1.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 2.7 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 10.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 3.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 2.2 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 8.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.1 | 2.3 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 3.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 1.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 2.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 1.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.9 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 2.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 4.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.1 | 1.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 4.1 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.1 | 0.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.1 | 1.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 2.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 14.5 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 4.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 0.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 2.4 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 2.1 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 1.7 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 19.0 | GO:0044297 | cell body(GO:0044297) |
| 0.1 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 12.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 2.8 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 1.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 1.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 61.9 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.0 | 52.8 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.8 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 2.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.0 | 3.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.0 | 0.4 | GO:0034702 | ion channel complex(GO:0034702) |
| 0.0 | 0.6 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 2.1 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 4.8 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 0.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.7 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 1.5 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 1.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.9 | GO:0098793 | presynapse(GO:0098793) |
| 0.0 | 0.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.4 | 19.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 5.7 | 39.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 5.2 | 26.0 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 3.5 | 14.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 3.1 | 9.4 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 3.1 | 9.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 2.9 | 8.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 2.3 | 2.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 2.1 | 34.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 2.1 | 18.9 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 2.1 | 26.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 2.1 | 6.2 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 1.9 | 7.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.8 | 5.5 | GO:0017129 | triglyceride binding(GO:0017129) |
| 1.8 | 9.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 1.8 | 5.4 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 1.7 | 5.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 1.7 | 5.0 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 1.7 | 13.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 1.6 | 19.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 1.6 | 4.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 1.5 | 19.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 1.4 | 4.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 1.4 | 8.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 1.4 | 4.2 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 1.3 | 4.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) procollagen galactosyltransferase activity(GO:0050211) |
| 1.3 | 6.7 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 1.3 | 3.8 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 1.3 | 15.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 1.2 | 8.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 1.2 | 3.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 1.2 | 12.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 1.1 | 3.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 1.1 | 6.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.1 | 9.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 1.1 | 8.9 | GO:0034711 | inhibin binding(GO:0034711) |
| 1.1 | 3.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 1.1 | 3.3 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 1.1 | 2.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 1.1 | 18.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 1.1 | 3.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 1.1 | 14.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 1.1 | 11.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 1.0 | 4.2 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 1.0 | 16.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 1.0 | 3.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 1.0 | 13.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 1.0 | 4.9 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 1.0 | 7.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 1.0 | 4.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.9 | 2.8 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.9 | 4.7 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.9 | 9.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.9 | 7.3 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.9 | 2.7 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.9 | 0.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.9 | 2.6 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.8 | 8.5 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
| 0.8 | 8.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.8 | 10.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.8 | 3.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.8 | 2.4 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.8 | 17.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.8 | 72.9 | GO:0005518 | collagen binding(GO:0005518) |
| 0.8 | 6.9 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.8 | 3.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.8 | 3.8 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.7 | 2.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.7 | 6.4 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.7 | 2.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.7 | 4.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.7 | 9.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.7 | 15.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.7 | 7.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.7 | 6.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.7 | 3.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.7 | 4.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.7 | 8.7 | GO:0031005 | filamin binding(GO:0031005) |
| 0.7 | 2.0 | GO:0086076 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 0.7 | 6.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.7 | 9.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.7 | 3.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.6 | 5.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.6 | 0.6 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.6 | 2.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.6 | 3.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.6 | 8.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.6 | 1.9 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.6 | 3.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.6 | 2.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.6 | 1.8 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.6 | 3.0 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.6 | 7.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.6 | 3.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.6 | 1.7 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.6 | 1.7 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.5 | 16.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.5 | 4.8 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.5 | 2.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.5 | 3.7 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.5 | 2.6 | GO:0071253 | connexin binding(GO:0071253) |
| 0.5 | 5.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.5 | 2.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.5 | 11.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.5 | 3.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.5 | 21.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.5 | 3.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.5 | 7.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.5 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.5 | 6.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.5 | 1.4 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.5 | 4.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.5 | 11.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.5 | 1.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.5 | 3.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.4 | 3.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.4 | 13.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.4 | 10.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.4 | 1.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.4 | 1.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.4 | 5.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.4 | 15.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.4 | 9.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.4 | 1.5 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.4 | 3.8 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.4 | 15.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.4 | 2.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.4 | 3.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.3 | 2.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.3 | 2.4 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.3 | 2.1 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.3 | 2.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.3 | 15.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.3 | 27.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.3 | 2.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.3 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.3 | 1.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.3 | 1.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.3 | 3.3 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.3 | 5.3 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 8.9 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.3 | 3.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.3 | 8.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.3 | 14.0 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.3 | 5.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.3 | 4.3 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 4.6 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.3 | 4.3 | GO:0019864 | IgG binding(GO:0019864) |
| 0.3 | 7.5 | GO:0001848 | complement binding(GO:0001848) |
| 0.3 | 3.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.3 | 2.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 6.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.3 | 6.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.3 | 3.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 2.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.3 | 4.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.3 | 4.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.3 | 3.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.3 | 1.1 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.3 | 1.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.3 | 1.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.3 | 2.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.3 | 2.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.3 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.3 | 6.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.2 | 12.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.2 | 4.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.2 | 25.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 1.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.2 | 4.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.2 | 2.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.2 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
| 0.2 | 6.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 2.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
| 0.2 | 3.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 2.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.2 | 2.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.2 | 8.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.2 | 4.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 0.9 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.2 | 4.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 10.3 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.2 | 1.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 1.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.2 | 3.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 3.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.2 | 3.8 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.2 | 2.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.2 | 5.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.2 | 0.8 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.2 | 1.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 2.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.2 | 0.9 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 1.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.2 | 2.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 6.1 | GO:0002039 | p53 binding(GO:0002039) |
| 0.2 | 4.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.2 | 11.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 10.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.2 | 7.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.2 | 1.8 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 0.5 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.2 | 2.9 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.2 | 1.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 1.7 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.2 | 1.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.2 | 2.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 2.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 2.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.1 | 1.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.1 | 2.4 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 1.6 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 10.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 2.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.1 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 4.4 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.1 | 2.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 1.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 3.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 1.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 9.3 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.5 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.1 | 0.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 30.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 47.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.1 | 1.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.1 | 0.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.1 | 2.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 2.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 5.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.1 | 5.8 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 2.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 4.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 1.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 9.9 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 0.4 | GO:0005497 | androgen binding(GO:0005497) |
| 0.1 | 27.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.1 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 1.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.9 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) extracellular ATP-gated cation channel activity(GO:0004931) nucleotide receptor activity(GO:0016502) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 4.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.1 | 4.9 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.1 | 0.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 3.6 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.1 | 10.8 | GO:0005506 | iron ion binding(GO:0005506) |
| 0.1 | 3.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 1.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 4.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 3.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 1.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 5.4 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.1 | 8.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.1 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 0.7 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 1.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 1.0 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 6.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.0 | 1.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.8 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 4.4 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 1.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 1.3 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 1.4 | GO:0046906 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
| 0.0 | 0.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.0 | 0.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 0.0 | 2.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.7 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.0 | 3.0 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.0 | 0.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.0 | 0.4 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 0.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 1.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 0.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 69.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.8 | 27.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.7 | 13.6 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.6 | 33.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.6 | 26.3 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.6 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.5 | 9.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.5 | 12.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.5 | 13.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.5 | 7.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.4 | 3.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.4 | 14.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 3.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.3 | 26.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.3 | 2.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.3 | 14.0 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.3 | 5.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.3 | 4.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 8.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 6.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.2 | 9.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.2 | 11.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.2 | 8.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.2 | 2.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 1.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 6.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 10.0 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 9.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.2 | 52.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 3.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 4.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.2 | 35.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 6.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.2 | 8.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.2 | 5.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 6.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 3.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.2 | 9.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 2.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.2 | 5.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.2 | 0.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 25.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 2.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 3.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 5.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 4.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 4.1 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 3.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 2.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 4.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 30.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 2.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 1.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 3.0 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
| 0.1 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 1.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 1.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 1.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 1.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 1.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 1.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 2.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 1.7 | 46.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 1.4 | 36.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 1.3 | 17.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 1.2 | 4.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 1.1 | 16.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 1.1 | 1.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 1.1 | 69.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.9 | 26.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.8 | 1.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.6 | 7.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.6 | 24.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.6 | 11.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.6 | 6.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.5 | 11.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.5 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.5 | 7.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.5 | 10.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.5 | 14.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.5 | 3.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.5 | 7.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.5 | 8.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.5 | 24.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.4 | 7.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.4 | 18.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.4 | 1.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.4 | 5.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.4 | 6.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.4 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.4 | 6.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 5.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.3 | 7.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 16.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.3 | 6.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 11.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.3 | 1.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.3 | 9.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.3 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.3 | 6.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.3 | 7.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.3 | 1.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.3 | 13.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.3 | 11.3 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.3 | 9.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.3 | 8.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
| 0.3 | 11.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.3 | 3.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.3 | 1.8 | REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | Genes involved in Insulin receptor signalling cascade |
| 0.3 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.2 | 9.7 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.2 | 3.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 1.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.2 | 9.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 8.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.2 | 3.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.2 | 6.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.2 | 5.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.2 | 3.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.2 | 8.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.2 | 2.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 3.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.2 | 1.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 2.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 4.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 1.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.1 | 4.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 11.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 6.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 1.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 10.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 5.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 10.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 2.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 6.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 1.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.1 | 22.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 5.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.1 | 2.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 9.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 3.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 2.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 3.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 1.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 2.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 1.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.1 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 2.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 2.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 1.5 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
| 0.1 | 1.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 0.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 1.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.1 | 2.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 0.8 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
| 0.1 | 5.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 1.0 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
| 0.1 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 5.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 7.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 1.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 1.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 2.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.8 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
| 0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 1.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |